Pharmaceutical Business Review
Return to: PBR Home | Suppliers

First Application of Haselmeier's Axis-D Injection Pen in Launched

Published 15 March 2012 | By Haselmeier

Haselmeier has announced that the first application of its Axis-D pen platform has been launched. Commissioned by its client Merck Serono, a division of Merck KGaA, Germany, the new injection device has been designed to allow self injection by patients of a ready to use biopharmaceutical solution for injection.

Available Downloads

First Application of Haselmeier's Axis-D Injection Pen in Launched